(Q50940837)
Statements
A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia. (English)
1 reference
D A Papanicolaou
1 reference
S N Ather
1 reference
H Zhu
1 reference
Y Zhou
1 reference
J Lutkiewicz
1 reference
B B Scott
1 reference
J Chandler
1 reference
1 January 2013
1 reference
17
1 reference
6
1 reference
533-543
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference